Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
28.53
+1.01 (3.67%)
At close: Apr 30, 2026, 4:00 PM EDT
28.85
+0.32 (1.11%)
After-hours: Apr 30, 2026, 7:54 PM EDT
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $20.42 billion as of April 30, 2026. Its market cap has increased by 180.82% in one year.
Market Cap
20.42B
Enterprise Value
16.00B
1-Year Change
180.82%
Ranking
Category
Stock Price
$28.53
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $20.42B, an increase of 3,728.25%. That is a compound annual growth rate of 96.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 19.70B | 30.51% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 30.45B |
| Royalty Pharma | 29.37B |
| Insmed | 29.13B |
| BioNTech SE | 25.81B |
| Incyte | 19.47B |
| Moderna | 18.70B |
| Summit Therapeutics | 16.50B |
| Genmab | 16.26B |